[For an efficient and reasonable accreditation of allergen specific IgE]

Anne Sarrat1, Séverine Brabant, Eric Charbonnier

  • 1Laboratoire d'immunologie, CHU Bordeaux, Hôpital Pellegrin, Bordeaux, France. anne.sarrat@chu-bordeaux.fr

Insights

Medical labs need accreditation for specific IgE testing. A proposed validation process, using Dermatophagoides pteronyssinus as a representative allergen, ensures reliable results for laboratory accreditation.

Area of Science:

  • Clinical chemistry and immunology
  • In vitro diagnostics (IVD)

Context:

  • French medical laboratories require NF/EN/ISO 15189 accreditation.
  • Standard accreditation guidelines are challenging for specific IgE determination due to numerous allergens and lack of a gold standard.
  • Specific IgE testing methods are CE marked, automated, and standardized.

Purpose:

  • To propose a practical and scientifically sound validation process for specific IgE determination in medical laboratories.
  • To meet accreditation requirements (NF/EN/ISO 15189) for specific IgE testing.
  • To ensure reliable and comparable performance of specific IgE assays.

Summary:

  • A validation strategy is proposed, focusing on a representative allergen (Dermatophagoides pteronyssinus) for key performance metrics like precision and reproducibility.
  • Internal Quality Control (IQC) and external quality controls (EQCs) are recommended for accuracy assessment.
  • Methodology addresses instrument changes and linearity checks, providing a reasonable approach to accreditation.

Impact:

  • Enables medical laboratories to achieve accreditation for specific IgE testing.
  • Ensures high-quality diagnostic performance, benefiting allergologists and patients.
  • Provides a cost-effective and technically feasible solution for laboratory validation.

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

Overview
Antibody Structure01:10

Antibody Structure

Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Enzyme-Linked Immunosorbent Assay01:33

Enzyme-Linked Immunosorbent Assay

In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen.  Enzyme-substrate reaction allows the antigen to be visualized or quantified.
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...